Cointime

Castle Creek Biosciences

company

About

Castle Creek Biosciences is focused on developing commercializing novel, personalized gene therapies for rare skin disorders.

  • 11 - 50

Highlights

Total Funding Amount
$20M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
$20M
Industries
Biopharma,Biotechnology,Life Science,Pharmaceutical
Founded date
Jan 1, 2015
Number Of Employee
11 - 50
Operating Status
Active

Castle Creek Biosciences is focused on developing and commercializing novel, personalized gene therapies for rare skin and connective tissue disorders with high unmet need.

It was founded in 2015 and headquartered in Pennsylvania, United States.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$20M
Castle Creek Biosciences has raised a total of $20M in funding over 2 rounds. Their latest funding was raised on Mar 25, 2020 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 25, 2020 Debt Financing $20M 1 Horizon Technology Finance — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Castle Creek Biosciences is funded by 1 investors. Horizon Technology Finance are the most recent investors.
Investor Name Lead Investor Funding Round
Horizon Technology Finance Yes Debt Financing
Cointime
เนื้อหา
บริษัท